Total Funding
1
Total FundingGrant raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
VitamFero is a privately held biotech company whose mission, founded on an innovative and patented technology.
- Alain De la Bigne: Co-Founder & Partner
About the Company
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as:
- Toxoplasma gondii (toxoplasmosis agent)
- Neospora caninum
(neosporosis agent)
- Cryptosporidium parvum (cryptosporidiosis agent).
With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.
